Contents

Search


aluminum hydroxide (Alternagel, Amphojel, Alu-Cap, Dialume, AlH3OH)

Tradename: Alternagel, Amphojel, Alu-Cap, Dialume. Al(OH)3 Indications: 1) symptomatic treatment of dyspepsia, peptic ulcer, GERD, hiatal hernia 2) hyperphosphatemia in non-renal impaired patients 3) skin irritation, including diaper rash [4] 4) stress ulcer prophylaxis [4] Contraindications: pregnancy-category :value +, ? 1st trimester safety-in-lactation :value ? Dosage: 1) 500-1500 mg PO up to 6 times daily 2) 1-3 capsules 1-3 hours after meals & QHS PRN Tabs: 300(?), 475, 500, 600(?) mg. Suspension: 1) 320 mg/5 mL, 450 mg/5 mL, 600 mg/5 mL, 675 mg/5 mL. 2) 5-30 mL 1 & 3 hours after meals & QHS PRN Pharmacokinetics: 1) elimination :route kidney 2) usual duration of action is 20-60 minutes if taken after meals 3) effects may persist for up to 3 hours Adverse effects: 1) common (> 10%) - constipation - chalky taste - stomach cramps - fecal impactation 2) less common (1-10%) - nausea/vomiting, discoloration of feces (white speckles) 3) uncommon (< 1%) - hypophosphatemia, hypomagnesemia 3) other - decrease in GI motility - long term use in patients with renal failure may result in aluminum toxicity Drug interactions: - decreased absorption of many medications including: - tetracyclines, digoxin, iron salts, isoniazid, allopurinol, corticosteroids, penicillamine, phenothiazines, H2 receptor antagonists Mechanism of action: 1) increased pH of gastric secretions 2) aluminum binds phosphate in food within the intestine

Interactions

drug interactions drug adverse effects of antacid(s)

Related

Al+3 (aluminum ion)

General

antacid phosphate binder

Database Correlations

PUBCHEM cid=3026338

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. Deprecated Reference

Component-of

aluminum hydroxide/aspirin/magnesium hydroxide (Ascriptin) aluminum hydroxide/dimethicone/magnesium hydroxide aluminum hydroxide/diphenhydramine/lidocaine/magnesium hydroxide/simethicone aluminum hydroxide/magnesium carbonate (Gaviscon) aluminum hydroxide/magnesium hydroxide (Maalox, Mylanta) aluminum hydroxide/magnesium hydroxide/ribonuclease/angiogenin inhibitor/simethicone aluminum hydroxide/magnesium hydroxide/simethicone (Mylanta II, Maalox Plus) aluminum hydroxide/magnesium trisilicate